A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
Phase
2Span
130 weeksSponsor
Boehringer IngelheimAmagasaki
Recruiting
Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults.
Phase
3Span
250 weeksSponsor
PfizerAmagasaki, Hyōgo
Recruiting
Healthy Volunteers
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
Phase
3Span
214 weeksSponsor
Alpine Immune Sciences Inc, A Subsidiary of VertexAmagasaki
Recruiting
1-3 of 3